alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEET AT JUNE 30, 1999 (UNAUDITED) AND THE CONSOLIDATED
STATEMENT OF OPERATIONS FOR THE SIX MONTHS ENDED JUNE 30, 1999 (UNAUDITED) AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                             575
<SECURITIES>                                         0
<RECEIVABLES>                                   17,836
<ALLOWANCES>                                     (868)
<INVENTORY>                                     26,272
<CURRENT-ASSETS>                                46,793
<PP&E>                                          27,567
<DEPRECIATION>                                (13,487)
<TOTAL-ASSETS>                                  63,356
<CURRENT-LIABILITIES>                           25,190
<BONDS>                                         13,487
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            59
<OTHER-SE>                                      21,517
<TOTAL-LIABILITY-AND-EQUITY>                    63,356
<SALES>                                         68,955
<TOTAL-REVENUES>                                77,870
<CGS>                                           46,318
<TOTAL-COSTS>                                   57,416
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0<F1>
<INTEREST-EXPENSE>                                 798
<INCOME-PRETAX>                                  2,307
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              2,307
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,307
<EPS-BASIC>                                        .40
<EPS-DILUTED>                                      .39
<FN>
<F1>PROVISION FOR DOUBTFUL ACCOUNTS AND INVENTORY PROVISION INCLUDED IN TOTAL
COSTS.
</FN>


</TABLE>
Exhibit 32.2



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of U.S. Restaurant Properties, Inc., (the Company) on Form 10-K for the year ended December 31, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, Stacy M. Riffe, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:



(1) The Report fully complies with the requirements of
section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15U.S.C. 78m or 78o(d)); and



(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                  |  |                        
|----------------- |  | -----------------------
|February 24, 2005 |  | /s/ STACY M. RIFFE     
|                  |  | Stacy M. Riffe         
|                  |  | Chief Financial Officer
<TABLE> <S> <C>

<ARTICLE> 7
<MULTIPLIER> 1,000,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               DEC-31-1999
<DEBT-HELD-FOR-SALE>                            17,035
<DEBT-CARRYING-VALUE>                                0
<DEBT-MARKET-VALUE>                                  0
<EQUITIES>                                         153
<MORTGAGE>                                         200
<REAL-ESTATE>                                        0
<TOTAL-INVEST>                                  21,786
<CASH>                                              89
<RECOVER-REINSURE>                                 449
<DEFERRED-ACQUISITION>                           4,210
<TOTAL-ASSETS>                                 139,033
<POLICY-LOSSES>                                  6,236
<UNEARNED-PREMIUMS>                                 48
<POLICY-OTHER>                                  16,873
<POLICY-HOLDER-FUNDS>                          110,652
<NOTES-PAYABLE>                                    650
<PREFERRED-MANDATORY>                                1
<PREFERRED>                                        250<F1>
<COMMON>                                             0
<OTHER-SE>                                       2,305
<TOTAL-LIABILITY-AND-EQUITY>                   139,033
<PREMIUMS>                                       3,979
<INVESTMENT-INCOME>                              1,562
<INVESTMENT-GAINS>                                 (5)
<OTHER-INCOME>                                       0
<BENEFITS>                                       3,054
<UNDERWRITING-AMORTIZATION>                        568
<UNDERWRITING-OTHER>                             1,130
<INCOME-PRETAX>                                    686
<INCOME-TAX>                                       219
<INCOME-CONTINUING>                                467
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       467
<EPS-BASIC>                                       3.34
<EPS-DILUTED>                                     3.33
<RESERVE-OPEN>                                       0
<PROVISION-CURRENT>                                  0
<PROVISION-PRIOR>                                    0
<PAYMENTS-CURRENT>                                   0
<PAYMENTS-PRIOR>                                     0
<RESERVE-CLOSE>                                      0
<CUMULATIVE-DEFICIENCY>                              0
<FN>
<F1>REPRESENTS COMPANY OBLIGATED MANDATORILY REDEEMABLE PREFERRED SECURITIES OF
SUBSIDIARY TRUST HOLDING SOLELY PARENT JUNIOR SUBORDINATED DEBENTURES.
</FN>


</TABLE>
#### STATE ex rel. Albert PATTERSON v. STATE of Louisiana.

No. 2010-KH-2470.

Supreme Court of Louisiana.

Nov. 4, 2011.

In re Patterson, Albert; — Plaintiff; Applying For Supervisory and/or Remedial Writs, Parish of E. Baton Rouge, 19th Judicial District Court Div. N, No. 09-87-0498; to the Court of Appeal, First Circuit, No. 2010 KW 1167.

Denied.
<TABLE> <S> <C>


<ARTICLE> 9
<CIK> 0000920107
<NAME> TSB FINANCIAL, INC.
<MULTIPLIER> 1
<CURRENCY>   US DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1997
<PERIOD-START>                             APR-01-1997
<PERIOD-END>                               JUN-30-1997
<EXCHANGE-RATE>                                      1
<CASH>                                       1,131,640
<INT-BEARING-DEPOSITS>                         290,733
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                  4,045,047
<INVESTMENTS-CARRYING>                         355,711
<INVESTMENTS-MARKET>                           362,589
<LOANS>                                     23,993,447
<ALLOWANCE>                                          0
<TOTAL-ASSETS>                              30,822,732
<DEPOSITS>                                  21,826,963
<SHORT-TERM>                                 4,858,657
<LIABILITIES-OTHER>                            161,032
<LONG-TERM>                                          0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         2,699
<OTHER-SE>                                   3,973,381
<TOTAL-LIABILITIES-AND-EQUITY>              30,822,732
<INTEREST-LOAN>                                486,739
<INTEREST-INVEST>                               98,476
<INTEREST-OTHER>                                18,131
<INTEREST-TOTAL>                               603,346
<INTEREST-DEPOSIT>                             255,204
<INTEREST-EXPENSE>                              73,569
<INTEREST-INCOME-NET>                          256,442
<LOAN-LOSSES>                                    4,500
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                161,823
<INCOME-PRETAX>                                108,250
<INCOME-PRE-EXTRAORDINARY>                     108,250
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    72,000
<EPS-PRIMARY>                                     0.33
<EPS-DILUTED>                                     0.29
<YIELD-ACTUAL>                                     7.9
<LOANS-NON>                                    101,314
<LOANS-PAST>                                   101,314
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                               133,284
<CHARGE-OFFS>                                        0
<RECOVERIES>                                     3,655
<ALLOWANCE-CLOSE>                              141,439
<ALLOWANCE-DOMESTIC>                           141,439
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        


</TABLE>
News United States Air Force
 Global U-2 Flying Operations Not Impacted by recent crashPublished Sept. 23, 2016
                        
                        By 9th Reconnaissance Wing Public Affairs
                        
                        
                        9th Reconnaissance Wing Public Affairs
                **BEALE AIR FORCE BASE, Calif. (AFNS) --**
                Worldwide flying operations for the U-2 have not been impacted as a result of a recent crash here on Sept. 20.
The demand signal for the U-2 to continue supporting combatant commanders and meet national security objectives has not diminished. The aircraft continues to be flown globally by highly trained pilots.
As a result of the crash, Beale Air Force Base put a hold on local flying training missions in order to respond to the incident. The 9th Reconnaissance Wing intends to return to normal flying operations this week.
“Our ability to fly missions in support of commanders has not been impacted by the recent crash. We continue to carry out our mission of providing high altitude (intelligence, surveillance and reconnaissance) and delivering that decision advantage to combatant commanders,” said Col. Larry Broadwell, the 9th RW commander. 
The aircraft crash is currently under investigation.ISR 



ACC 



U-2 



Beale AFB
#### ANDREW S. RAJCOK *v.*STOP AND SHOP COMPANIES, INC.

(AC 23356)

Lavery, C. J., and Foti and Flynn, Js.

Submitted on briefs May 2

officially released June 10, 2003

Per Curiam.

The judgment is affirmed.
**Exhibit 32.1**

 

**CERTIFICATION PURSUANT TO**

**SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

 

In connection with the Quarterly Report on Form 10-Q of Point Therapeutics, Inc. (the “Company”) for the three and six-month periods endedJune 30, 2003 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Donald R. Kiepert, Jr., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuantto Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge: 

 

(1)    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

 

(2)    The information contained in the Report fairly presents, in all material respects, the financial conditions and results ofoperations of the Company. 

 

Dated: August 13, 2003 

 

A signed original of this written statement required by Section 906 has beenprovided to Point Therapeutics, Inc. and will be retained by Point Therapeutics, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

###### Foreign-Trade Zones Board

Foreign-Trade Zone 189 was approved by the FTZ Board on January 15, 1993 (Board Order 616, 58 FR 6614, 2/1/1993) and currently consists of seven “sites” totaling 236 acres in Kent, Ottawa and Muskegon Counties, Michigan. The current update does not alter the physical boundaries that have previously been approved, but instead involves an administrative renumbering that separates certain non-contiguous sites for record-keeping purposes.

                    Under this revision, the site list for FTZ 189 will be as follows:                     *Site 1*                     (8 acres) located at 44th Street and Clay Avenue in the City of Wyoming, Kent County;                     *Site 2*                     (18 acres) located at 1920 Lakeshore Drive in the City of Muskegon, Muskegon County;                     *Site 3*                     (64 acres) located at 5353 52nd Street in Cascade Township, Kent County, adjacent to Kent County International Airport;                     *Site 4*                     (40 acres) located at 500 Mart Street in the City of Muskegon, Muskegon County;                     *Site 5*                     (5 acres) located at 449 Howard Avenue in Holland Township in Ottawa County;                     *Site 6*                     (80 acres) located at 48th & Thornapple River Drive in Cascade Township, Kent County;                     *Site 7*                     (500,000 sq. ft.) located at 1210 and 1218 East Pontaluna Road, Norton Shores, Muskegon County;                     *Site 8*                     (15 acres) located at 900 Hall Street SW., Grand Rapids, Kent County; and,                     *Site 9*                     (6 acres) located at 2900 Dixie Street, Grandville, Kent County.                

                    For further information, contact Elizabeth Whiteman at                     *Elizabeth.Whiteman@trade.gov*                     or (202) 482-0473.                

Dated: September 20, 2010.

Andrew McGilvray,

Executive Secretary.

[FR Doc. 2010-24033 Filed 9-23-10; 8:45 am]

BILLING CODE P
583 A.2d 331

#### STATE OF NEW JERSEY v. GREGORY J. BARTHOLOMEW.

March 7, 1990.

Petition for certification denied.
I 

110TH CONGRESS 

1ST SESSION H. R. 1323 

To authorize a major medical facility project for the Department of Veterans 

Affairs at Denver, Colorado. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 5, 2007 

Mr. SALAZAR (for himself and Mr. PERLMUTTER) introduced the following 

bill; which was referred to the Committee on Veterans’ Affairs 

A BILL 

To authorize a major medical facility project for the 

Department of Veterans Affairs at Denver, Colorado. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. AUTHORIZATION OF MAJOR MEDICAL FACILITY 

4 PROJECT, DENVER, COLORADO. 

5 The Secretary of Veterans Affairs may carry out a 

6 major medical facility project for a replacement facility for 

7 the Department of Veterans Affairs Medical Center, Den8 ver, Colorado, in an amount not to exceed $523,000,000. 


jcorcoran on PROD1PC62 with BILLS
2 

•HR 1323 IH

1 SEC. 2. AUTHORITY FOR USE OF EXISTING FUNDS. 

2 The Secretary of Veterans Affairs may obligate and 

3 expend any unobligated amount in the ‘‘Construction, 

4 Major Projects’’ account of the Department of Veterans 

5 Affairs to purchase a site for, and for the construction 

6 of, the Department of Veterans Affairs replacement facil7 ity authorized in section 1. 

Æ 


jcorcoran on PROD1PC62 with BILLS
Appeal Dismissed and Memorandum Opinion filed July 10, 2012.

In The

Fourteenth Court of Appeals 

____________

NO. 14-12-00273-CR

____________

LISA ANN BARFIELD, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from County Criminal Court at Law No. 2

Harris County, Texas

Trial Court Cause No. 1714161

MEMORANDUM OPINION

Appellant was convicted of driving while intoxicated and filed this appeal. The 

clerk's record reflects the trial court subsequently granted appellant’s motion for new trial.

Generally, we only have jurisdiction to consider an appeal by a criminal defendant 

when there has been a final judgment of conviction. See Workman v. State, 170 Tex. 

Crim. App. 621, 343 S.W.2d 446, 447 (1961); McKown v. State, 915 S.W.2d 160, 161 

(Tex. App. – Fort Worth 1996, no pet.). Because appellant has been granted a new trial, 

there is no final conviction to appeal. 
2

Accordingly, we dismiss the appeal. 

PER CURIAM

Panel consists of Chief Justice Hedges and Justices Seymore, Brown.

Do Not Publish C TEX. R. APP. P. 47.2(b)
<PAGE>

                                  Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of U.S. Microbics, Inc., (the "Company")
on Form 10-QSB for the period ending June 30, 2005, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), Robert C.
Brehm, Chief Executive Officer of the Company, certify to the best of my
knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13 (a) or 15 (d)
of the Securities and Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company.

                                            /s/ Robert C. Brehm
                                            --------------------------------
                                            Robert C. Brehm
                                            Chief Executive Officer

                                            August 22, 2005
#### J. A. Couch et als. v. O. M. Parker.

(No. 2749, Op. Book No. 4, p. —.)

Appeal from Coleman County.

Opinion by

White, P. J.

§ 436. *Contract, verbal, with regard to management of a stock of cattle on shares; limitation and estoppel.*Suit was brought by Parker for his interest in a stock of cattle which he claimed was placed in his possession and management under á verbal contract by which he was to *193control the stock for one year, and for his services receive a stated interest in kind in the cattle and their increase, and that if, at the expiration of the first year, he desired to continue the employment upon the same terms, he might do so, and the contract could, at his option, continue as long as three years. He kept the cattle for one year and up to the 1st day of May of the second year, when, as he alleges, appellants, in violation of the contract, sold the entire stock, appropriated, failed and refused to account to him for his interest, which, he avers, was so many head in kind of the different grades of cattle on hand and the prospective increase of the cattle which might be produced within the three years.

June 2, 1883.

The contract, being verbal, was, in law, binding only for one year; but if, after the expiration of the first year, the parties permitted him to go on in pursuance of its terms, they would be estopped from denying his rights under it, at least up to the time when, by their own acts, it was terminated.

437. *Speculative ancl hypothetical profits.*On the trial plaintiff was permitted to prove what he believed and supposed his interest in the stock would have been up to the date of the trial, including what his interest would have been in the increase or calves that the heifers might have produced up to that time. Such speculative, imaginary and hypothetical profits are too remote to be the basis of a legitimate claim. [Still v. Paschal, 41 Tex. 640; De La Zerda v. Korn, 25 Tex. Sup. 188.]

§ 438. *Counterclaim; evidence of.*Evidence is not admissible in proof of a counterclaim where it appeara upon the face of such claim that it did not grow out of, was incident to, nor connected with, plaintiff’s cause of' action. [Rev. Stats, art. 650.]

Reversed and remanded..
EXHIBIT
10.103


 


STRAIGHT
NOTE


 


 




	
  $200,000

  	
   

  	
  South El Monte,
  California

  	
   

  	
  August 29, 2003

  






 


For value received, Lee Pharmaceuticals promises to
pay Mark DiSalvo or order, at South El Monte, California the sum of TWO HUNDRED
THOUSAND DOLLARS, with interest from August 29, 2003, on unpaid principal at
the rate of twenty (20) per cent per annum; principal is payable monthly,
commencing on October 15, 2003, with monthly principal payments of $5,000. The
remaining principal balance of this note is due and payable on December 15,
2005.  Interest shall be calculated on
the basis of the unpaid principal balance daily, based on a 365-day year,
actual day month and payable monthly. 
Principal and interest shall be payable in lawful money of the United
States.  If action were instituted on
this note, I promise to pay such sum as the Court may fix as attorney’s
fees.  This note is secured by the
trademarks on the product brand OraStat®.


 


 


	
  AUGUST 29, 2003

  	
   

  	
  RONALD G. LEE

  	
   

  
	
   

  	
  Date

  	
  Lee Pharmaceuticals - Ronald G. Lee

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
  AUGUST 29, 2003

  	
   

  	
  MICHAEL L. AGRESTI

  	
   

  
	
   

  	
  Date

  	
  Lee Pharmaceuticals - Michael L. Agresti